tiprankstipranks
Trending News
More News >
Brainhole Technology Limited (HK:2203)
:2203
Hong Kong Market
Advertisement

Brainhole Technology Limited (2203) AI Stock Analysis

Compare
1 Followers

Top Page

HK:2203

Brainhole Technology Limited

(2203)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 4o)
Rating:46Neutral
Price Target:
HK$0.00
▼(-100.00% Downside)
The overall stock score is primarily driven by the company's poor financial performance, characterized by declining revenues, negative margins, and high leverage. Technical analysis provides some support with longer-term moving averages, but weak momentum and negative valuation metrics further weigh down the score.

Brainhole Technology Limited (2203) vs. iShares MSCI Hong Kong ETF (EWH)

Brainhole Technology Limited Business Overview & Revenue Model

Company DescriptionBrainhole Technology Limited (2203) is a company engaged in the technology and electronics sector, specializing in the development and manufacturing of advanced electronic products and solutions. The company focuses on leveraging cutting-edge technology to deliver innovative and efficient solutions catering to a wide range of industries and consumer needs.
How the Company Makes MoneyBrainhole Technology Limited generates revenue through the sale of its advanced electronic products and solutions. The company has established a diversified revenue model that includes direct sales to consumers, partnerships with other companies for product distribution, and potential service agreements for maintenance and support of their technology solutions. Significant factors contributing to its earnings include its ability to innovate and adapt to market demands, strategic partnerships, and its reputation in delivering high-quality products. The company might also engage in licensing agreements or collaborations that provide additional revenue streams.

Brainhole Technology Limited Financial Statement Overview

Summary
Brainhole Technology Limited is facing significant financial challenges with declining revenues, negative profitability margins, and high leverage. The company's financial health is concerning, with negative cash flows and a high debt-to-equity ratio, indicating potential liquidity and solvency risks.
Income Statement
15
Very Negative
The company has been experiencing declining revenues with a negative revenue growth rate of -14.79% TTM. Gross profit margin is negative at -9.31%, indicating costs exceed revenues. Net profit margin is significantly negative at -163.65%, reflecting substantial losses. EBIT and EBITDA margins are also deeply negative, showing operational inefficiencies.
Balance Sheet
25
Negative
The debt-to-equity ratio is high at 2.28 TTM, indicating significant leverage and potential financial risk. Return on equity is positive at 9.36% TTM, which is unusual given the negative net income, suggesting potential accounting anomalies. The equity ratio is low, indicating a reliance on debt financing.
Cash Flow
20
Very Negative
Operating cash flow is negative, indicating cash outflows from operations. Free cash flow is also negative, with a growth rate of -19.71% TTM, suggesting deteriorating cash generation. The operating cash flow to net income ratio is negative, highlighting cash flow challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue89.08M119.99M220.81M263.57M321.57M261.81M
Gross Profit-8.30M-6.45M27.63M48.54M54.11M33.52M
EBITDA-74.86M-88.09M-18.99M-34.46M-19.62M-37.50M
Net Income-145.78M-127.88M-34.12M-57.61M-51.55M-58.76M
Balance Sheet
Total Assets135.27M152.74M279.20M333.42M353.63M370.34M
Cash, Cash Equivalents and Short-Term Investments76.59M74.80M111.75M107.92M42.64M74.15M
Total Debt63.70M163.71M138.78M147.44M84.93M113.13M
Total Liabilities107.35M211.81M212.43M231.84M211.31M183.70M
Stockholders Equity27.92M-59.07M66.76M101.58M142.32M186.64M
Cash Flow
Free Cash Flow-27.44M-39.49M27.21M-113.92M-4.96M-18.72M
Operating Cash Flow-27.13M-38.96M32.19M-106.08M-535.00K-4.92M
Investing Cash Flow18.27M4.23M6.00M11.45M1.48M-55.08M
Financing Cash Flow-15.14M19.45M-20.10M76.53M-31.00M80.58M

Brainhole Technology Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.21
Price Trends
50DMA
0.22
Negative
100DMA
0.21
Positive
200DMA
0.20
Positive
Market Momentum
MACD
>-0.01
Positive
RSI
46.04
Neutral
STOCH
42.34
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2203, the sentiment is Negative. The current price of 0.21 is below the 20-day moving average (MA) of 0.22, below the 50-day MA of 0.22, and above the 200-day MA of 0.20, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 46.04 is Neutral, neither overbought nor oversold. The STOCH value of 42.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2203.

Brainhole Technology Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
HK$131.00M15.603.83%-13.07%-34.88%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
52
Neutral
HK$130.50M-15.65-2.32%-6.45%-596.43%
46
Neutral
HK$101.59M-41.46%-26.02%-4977.27%
46
Neutral
HK$98.83M-6.19%18.71%
46
Neutral
HK$172.00M-47.92%-869.15%
40
Underperform
HK$125.17M-0.9537.63%56.51%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2203
Brainhole Technology Limited
0.21
-0.05
-19.23%
HK:1679
Risecomm Group Holdings Limited
0.49
-0.04
-7.55%
HK:1912
Contel Technology Company Limited
0.07
-0.05
-41.67%
HK:1967
Confidence Intelligence Holdings Limited
0.40
-0.02
-4.76%
HK:8257
Genes Tech Group Holdings Company Limited
0.13
0.05
62.50%
HK:8490
Niche-Tech Semiconductor Materials Limited
0.14
-0.05
-26.32%

Brainhole Technology Limited Corporate Events

Brainhole Technology Granted Waiver for Circular Dispatch Delay
Oct 24, 2025

Brainhole Technology Limited, a company incorporated in the Cayman Islands, announced a delay in the dispatch of a circular related to the further disposal of Robinhood shares, which is a major transaction under Chapter 14 of the Listing Rules. The company has been granted a waiver from strict compliance with Rule 14.41(a) by the Stock Exchange, allowing them to dispatch the circular by November 21, 2025, due to the need for additional time to finalize financial information.

The most recent analyst rating on (HK:2203) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Brainhole Technology Limited stock, see the HK:2203 Stock Forecast page.

Brainhole Technology Expands Investment in TeraWulf
Oct 12, 2025

Brainhole Technology Limited has announced a further acquisition of 100,800 TeraWulf shares for approximately US$1.5 million. This acquisition, combined with previous purchases, totals approximately US$2.8 million, making it a discloseable transaction under Hong Kong’s Listing Rules. The acquisition was financed by proceeds from the disposal of Robinhood shares, and the transaction is expected to impact the company’s investment portfolio by increasing its stake in TeraWulf, a digital asset technology company.

The most recent analyst rating on (HK:2203) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Brainhole Technology Limited stock, see the HK:2203 Stock Forecast page.

Brainhole Technology Limited Announces Major Disposal of Robinhood Shares
Oct 12, 2025

Brainhole Technology Limited has announced a major transaction involving the further disposal of 12,700 Robinhood Shares, generating approximately US$1.9 million. This transaction, when aggregated with previous disposals, constitutes a major transaction under the Hong Kong Listing Rules, requiring shareholder approval, which has been obtained from Yoho Bravo Limited, holding a significant majority of the company’s shares. No extraordinary general meeting will be convened as a result.

The most recent analyst rating on (HK:2203) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Brainhole Technology Limited stock, see the HK:2203 Stock Forecast page.

Brainhole Technology Limited Announces Key Securities Transactions
Sep 11, 2025

Brainhole Technology Limited has announced two significant transactions involving the acquisition and disposal of listed securities. On September 11, 2025, the company acquired 119,500 TeraWulf shares for approximately US$1.3 million and disposed of 14,400 Tempus shares for approximately US$1.2 million. Both transactions are classified as discloseable under the Hong Kong Listing Rules, as they exceed the 5% threshold but remain below 25%, necessitating public announcement and reporting.

Brainhole Technology Limited Announces Change of Auditors
Sep 5, 2025

Brainhole Technology Limited has announced a change in its auditors due to a disagreement over the proposed auditor’s remuneration with SHINEWING (HK) CPA Limited. The company has appointed Prism Hong Kong Limited as the new auditors, citing their competitive proposals and industry expertise. The Board believes this change will enhance cost-effectiveness and maintain audit quality, benefiting the company and its shareholders.

Brainhole Technology Reports Interim Financial Results for 2025
Aug 27, 2025

Brainhole Technology Limited, a company incorporated in the Cayman Islands, announced its interim financial results for the six months ending June 30, 2025. The company reported a decrease in revenue from HK$83,084,000 in 2024 to HK$52,173,000 in 2025, resulting in a gross profit of HK$9,093,000. Despite an increase in other income, the company faced a loss before tax of HK$16,151,000 due to higher administrative expenses and impairment losses. The total comprehensive expense for the period was HK$15,174,000, indicating a challenging financial period for the company.

Brainhole Technology Schedules Board Meeting for Interim Results Review
Aug 15, 2025

Brainhole Technology Limited announced that its board of directors will meet on August 27, 2025, to review and approve the unaudited consolidated interim results for the first half of 2025. The meeting will also consider the declaration and payment of an interim dividend, which could impact the company’s financial strategy and shareholder returns.

Brainhole Technology Limited Engages in Strategic Securities Transactions
Aug 12, 2025

Brainhole Technology Limited has announced several transactions involving the acquisition and disposal of listed securities. The company acquired shares in Nebius, Tempus, and Robinhood, while disposing of shares in Coinbase and Innodata. These transactions are considered discloseable under the Hong Kong Stock Exchange Listing Rules, requiring public announcement and reporting.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 28, 2025